These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11406539)

  • 1. Prostate carcinomas developing in transgenic rats with SV40 T antigen expression under probasin promoter control are strictly androgen dependent.
    Asamoto M; Hokaiwado N; Cho YM; Takahashi S; Ikeda Y; Imaida K; Shirai T
    Cancer Res; 2001 Jun; 61(12):4693-700. PubMed ID: 11406539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of prostate carcinogenesis in probasin/SV40 T antigen transgenic rats by raloxifene, an antiestrogen with anti-androgen action, but not nimesulide, a selective cyclooxygenase-2 inhibitor.
    Zeng Y; Yokohira M; Saoo K; Takeuchi H; Chen Y; Yamakawa K; Matsuda Y; Kakehi Y; Imaida K
    Carcinogenesis; 2005 Jun; 26(6):1109-16. PubMed ID: 15731164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential.
    Masumori N; Thomas TZ; Chaurand P; Case T; Paul M; Kasper S; Caprioli RM; Tsukamoto T; Shappell SB; Matusik RJ
    Cancer Res; 2001 Mar; 61(5):2239-49. PubMed ID: 11280793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adenovirus-mediated tissue-targeted expression of a caspase-9-based artificial death switch for the treatment of prostate cancer.
    Xie X; Zhao X; Liu Y; Zhang J; Matusik RJ; Slawin KM; Spencer DM
    Cancer Res; 2001 Sep; 61(18):6795-804. PubMed ID: 11559553
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lack of effect of human c-Ha-ras proto-oncogene overexpression on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats.
    Hokaiwado N; Asamoto M; Cho YM; Tsuda H; Shirai T
    Cancer Sci; 2003 Dec; 94(12):1042-5. PubMed ID: 14662018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 accelerates multistep prostate carcinogenesis in vivo.
    Bruckheimer EM; Brisbay S; Johnson DJ; Gingrich JR; Greenberg N; McDonnell TJ
    Oncogene; 2000 Nov; 19(46):5251-8. PubMed ID: 11077442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostate cancer progression, metastasis, and gene expression in transgenic mice.
    Perez-Stable C; Altman NH; Mehta PP; Deftos LJ; Roos BA
    Cancer Res; 1997 Mar; 57(5):900-6. PubMed ID: 9041192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression profiling of the mouse prostate after castration and hormone replacement: implication of H-cadherin in prostate tumorigenesis.
    Wang XD; Wang BE; Soriano R; Zha J; Zhang Z; Modrusan Z; Cunha GR; Gao WQ
    Differentiation; 2007 Mar; 75(3):219-34. PubMed ID: 17288544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Elevated expression of 12/15-lipoxygenase and cyclooxygenase-2 in a transgenic mouse model of prostate carcinoma.
    Shappell SB; Olson SJ; Hannah SE; Manning S; Roberts RL; Masumori N; Jisaka M; Boeglin WE; Vader V; Dave DS; Shook MF; Thomas TZ; Funk CD; Brash AR; Matusik RJ
    Cancer Res; 2003 May; 63(9):2256-67. PubMed ID: 12727848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of bcl-2 expression and bax deficiency on prostate homeostasis in vivo.
    Bruckheimer EM; Cho S; Brisbay S; Johnson DJ; Gingrich JR; Greenberg N; McDonnell TJ
    Oncogene; 2000 May; 19(20):2404-12. PubMed ID: 10828882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Castration-induced apoptosis of androgen-dependent shionogi carcinoma is associated with increased expression of genes encoding insulin-like growth factor-binding proteins.
    Nickerson T; Miyake H; Gleave ME; Pollak M
    Cancer Res; 1999 Jul; 59(14):3392-5. PubMed ID: 10416600
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression.
    Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B
    Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lack of significant modifying effect of arctiin on prostate carcinogenesis in probasin/SV40 T antigen transgenic rats.
    Zeng Y; Yokohira M; Takeuchi H; Saoo K; Yamakawa K; Matsuda Y; Hosokawa K; Li JQ; Ikeda M; Imaida K
    Cancer Lett; 2005 May; 222(2):145-51. PubMed ID: 15863263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of dutasteride on prostate growth in the large probasin-large T antigen mouse model of prostate cancer.
    Shao TC; Li H; Ittmann M; Cunningham GR
    J Urol; 2007 Oct; 178(4 Pt 1):1521-7. PubMed ID: 17707058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of Apc in the mouse prostate causes prostate carcinoma.
    Bruxvoort KJ; Charbonneau HM; Giambernardi TA; Goolsby JC; Qian CN; Zylstra CR; Robinson DR; Roy-Burman P; Shaw AK; Buckner-Berghuis BD; Sigler RE; Resau JH; Sullivan R; Bushman W; Williams BO
    Cancer Res; 2007 Mar; 67(6):2490-6. PubMed ID: 17363566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Castration-induced increases in insulin-like growth factor-binding protein 2 promotes proliferation of androgen-independent human prostate LNCaP tumors.
    Kiyama S; Morrison K; Zellweger T; Akbari M; Cox M; Yu D; Miyake H; Gleave ME
    Cancer Res; 2003 Jul; 63(13):3575-84. PubMed ID: 12839944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate targeting: PSP94 gene promoter/enhancer region directed prostate tissue-specific expression in a transgenic mouse prostate cancer model.
    Gabril MY; Onita T; Ji PG; Sakai H; Chan FL; Koropatnick J; Chin JL; Moussa M; Xuan JW
    Gene Ther; 2002 Dec; 9(23):1589-99. PubMed ID: 12424611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development, progression, and androgen-dependence of prostate tumors in probasin-large T antigen transgenic mice: a model for prostate cancer.
    Kasper S; Sheppard PC; Yan Y; Pettigrew N; Borowsky AD; Prins GS; Dodd JG; Duckworth ML; Matusik RJ
    Lab Invest; 1998 Mar; 78(3):319-33. PubMed ID: 9520945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the autochthonous transgenic adenocarcinoma of the mouse prostate (TRAMP) as a model to study effects of castration therapy.
    Wikström P; Lindahl C; Bergh A
    Prostate; 2005 Feb; 62(2):148-64. PubMed ID: 15389804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.